Pantazis N, Touloumi G, Meyer L, Olson A, Costagliola D, Kelleher AD, Lutsar I, Chaix M-L, Fisher M, Moreno S, et al. The impact of transient combination antiretroviral treatment in early HIV infection on viral suppression and immunologic response in later treatment. AIDS (London, England). 2016;30:879.
Judd A, Collins I, Lodi S, Olson A, Pantazis N, Del Amo J, Duff C, Gennotte A-F, Kristensen D, Ledergerber B, et al. Children and young people with perinatal HIV in Europe: epidemiological situation in 2014 and implications for the future. EUROSURVEILLANCE. 2016;21:20–26.
Simmons R, Malyuta R, Chentsova N, Karnets I, Murphy G, Medoeva A, Kruglov Y, Yurchenko A, Copas A, Porter K, et al. HIV Incidence Estimates Using the Limiting Antigen Avidity EIA Assay at Testing Sites in Kiev City, Ukraine: 2013-2014. PloS one. 2016;11:e0157179.
Olson AD, Walker SA, Suthar AB, Sabin C, Bucher HC, Jarrin I, Moreno S, Perez-Hoyos S, Porter K, Ford D.
Limiting cumulative HIV viremia copy-years by early treatment reduces risk of AIDS and death. Journal of acquired immune deficiency syndromes (1999). 2016;73:100.
Nakagawa F, van Sighem A, Thiebaut R, Smith C, Ratmann O, Cambiano V, Albert J, Amato-Gauci A, Bezemer D, Campbell C, et al. A method to estimate the size and characteristics of HIV-positive populations using an individual-based stochastic simulation model. Epidemiology (Cambridge, Mass.). 2016;27:247.
Hoffmann M, Pantazis N, Martin GE, Hickling S, Hurst J, Meyerowitz J, Willberg CB, Robinson N, Brown H, Fisher M, et al. Exhaustion of activated CD8 T cells predicts disease progression in primary HIV-1 infection. PLoS pathogens. 2016;12:e1005661.